186 related articles for article (PubMed ID: 30865322)
1. Evaluation of a low-dose desoxycorticosterone pivalate treatment protocol for long-term management of dogs with primary hypoadrenocorticism.
Sieber-Ruckstuhl NS; Reusch CE; Hofer-Inteeworn N; Kuemmerle-Fraune C; Müller C; Hofmann-Lehmann R; Boretti FS
J Vet Intern Med; 2019 May; 33(3):1266-1271. PubMed ID: 30865322
[TBL] [Abstract][Full Text] [Related]
2. [Therapy of primary hypoadrenocorticism in dogs with low dose desoxycorticosterone pivalate].
Münch L; Münch M; Paul H; Miklis A; Heinrich M; Neiger R
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2020 Jun; 48(3):171-175. PubMed ID: 32557492
[TBL] [Abstract][Full Text] [Related]
3. Desoxycorticosterone Pivalate Duration of Action and Individualized Dosing Intervals in Dogs with Primary Hypoadrenocorticism.
Jaffey JA; Nurre P; Cannon AB; DeClue AE
J Vet Intern Med; 2017 Nov; 31(6):1649-1657. PubMed ID: 28892205
[TBL] [Abstract][Full Text] [Related]
4. Use of plasma renin activity to monitor mineralocorticoid treatment in dogs with primary hypoadrenocorticism: desoxycorticosterone versus fludrocortisone.
Baumstark ME; Nussberger J; Boretti FS; Baumstark MW; Riond B; Reusch CE; Sieber-Ruckstuhl NS
J Vet Intern Med; 2014; 28(5):1471-8. PubMed ID: 25274440
[TBL] [Abstract][Full Text] [Related]
5. Lower initial dose desoxycorticosterone pivalate for treatment of canine primary hypoadrenocorticism.
Bates JA; Shott S; Schall WD
Aust Vet J; 2013 Mar; 91(3):77-82; discussion 81-2. PubMed ID: 23438457
[TBL] [Abstract][Full Text] [Related]
6. Treatment and long-term follow-up of 205 dogs with hypoadrenocorticism.
Kintzer PP; Peterson ME
J Vet Intern Med; 1997; 11(2):43-9. PubMed ID: 9127289
[TBL] [Abstract][Full Text] [Related]
7. Desoxycorticosterone pivalate in the management of canine primary hypoadrenocorticism.
Van Zyl M; Hyman WB
J S Afr Vet Assoc; 1994 Sep; 65(3):125-9. PubMed ID: 7595920
[TBL] [Abstract][Full Text] [Related]
8. Subcutaneous administration of desoxycorticosterone pivalate for the treatment of canine hypoadrenocorticism.
McCabe MD; Feldman EC; Lynn RC; Kass PH
J Am Anim Hosp Assoc; 1995; 31(2):151-5. PubMed ID: 7773761
[TBL] [Abstract][Full Text] [Related]
9. Low-dose desoxycorticosterone pivalate treatment of hypoadrenocorticism in dogs: A randomized controlled clinical trial.
Vincent AM; Okonkowski LK; Brudvig JM; Refsal KR; Berghoff N; Olivier NB; Langlois DK
J Vet Intern Med; 2021 Jul; 35(4):1720-1728. PubMed ID: 34114259
[TBL] [Abstract][Full Text] [Related]
10. Clinical features and long-term management of cats with primary hypoadrenocorticism using desoxycorticosterone pivalate and prednisolone.
Sieber-Ruckstuhl NS; Harburger L; Hofer N; Kümmerle C; Müller C; Riond B; Hofmann-Lehmann R; Reusch CE; Boretti FS
J Vet Intern Med; 2023 Mar; 37(2):420-427. PubMed ID: 36809682
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of microcrystalline desoxycorticosterone pivalate for treatment of hypoadrenocorticism in dogs. DOCP Clinical Study Group.
Lynn RC; Feldman EC; Nelson RW
J Am Vet Med Assoc; 1993 Feb; 202(3):392-6. PubMed ID: 8440628
[TBL] [Abstract][Full Text] [Related]
12. Effects of desoxycorticosterone pivalate administration on blood pressure in dogs with primary hypoadrenocorticism.
Kaplan AJ; Peterson ME
J Am Vet Med Assoc; 1995 Feb; 206(3):327-31. PubMed ID: 7751240
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of a cat with primary hypoadrenocorticism and severe hyponatremia with desoxycorticosterone pivalate (DOCP).
Woolcock AD; Ward C
Can Vet J; 2015 Nov; 56(11):1158-60. PubMed ID: 26538671
[TBL] [Abstract][Full Text] [Related]
14. Urine electrolytes do not predict desoxycorticosterone pivalate efficacy in dogs with hypoadrenocorticism.
Langlois DK; Dropkin CA; Kruger JM
Am J Vet Res; 2023 Aug; 84(8):. PubMed ID: 37279885
[TBL] [Abstract][Full Text] [Related]
15. Treatment of canine hypoadrenocorticism with microcrystalline desoxycorticosterone pivalate.
Lynn RC; Feldman EC
Br Vet J; 1991; 147(5):478-83. PubMed ID: 1959020
[TBL] [Abstract][Full Text] [Related]
16. Randomised clinical non-inferiority trial comparing two formulations of desoxycortone pivalate for the treatment of canine primary hypoadrenocorticism.
Farr H; Mason BL; Longhofer SL
Vet Rec; 2020 Jul; 187(2):e12. PubMed ID: 31974265
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of symmetric dimethylarginine and creatinine in dogs with primary hypoadrenocorticism receiving long-term mineralocorticoid replacement therapy.
Casado Díaz JI; Sieber-Ruckstuhl NS; Boretti FS; Fracassi F; Reusch CE
Vet Rec; 2022 Jan; 190(1):e242. PubMed ID: 33870518
[TBL] [Abstract][Full Text] [Related]
18. Altered Serum Thyrotropin Concentrations in Dogs with Primary Hypoadrenocorticism before and during Treatment.
Reusch CE; Fracassi F; Sieber-Ruckstuhl NS; Burkhardt WA; Hofer-Inteeworn N; Schuppisser C; Stirn M; Hofmann-Lehmann R; Boretti FS
J Vet Intern Med; 2017 Nov; 31(6):1643-1648. PubMed ID: 29024024
[TBL] [Abstract][Full Text] [Related]
19. Generalized vitiligo in a dog with primary hypoadrenocorticism.
Malerba E; Morini M; Fracassi F
Vet Dermatol; 2015 Oct; 26(5):376-8, e86. PubMed ID: 26104920
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and treatment of naturally occurring hypoadrenocorticism in 42 dogs.
Melián C; Peterson ME
J Small Anim Pract; 1996 Jun; 37(6):268-75. PubMed ID: 8805097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]